Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases - A Phase II Clinical Trial

NCT06888973 is registered in ClinicalTrials.gov with National Institute of Blood and Marrow Transplant (NIBMT), Pakistan as lead sponsor.

NCT NCT06888973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06888973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases - A Phase II Clinical Trial
Lead sponsor
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
Phase
Phase 1/2
Overall status
Enrolling by invitation
Start date
February 1, 2025
Completion date
February 1, 2026
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis (as), juvenile idiopathic arthritis, polymyositis/dermatomyositis, rheumatoid arthritis, systemic lupus erythematosus (sle), systemic sclerosis